Journey Medical (DERM) Revenue (2020 - 2026)

Journey Medical (DERM) has reported Revenue for 7 consecutive years, with $18.5 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Revenue rose 23.33% year-over-year to $18.5 million; the trailing twelve-month figure through Jun 2026 stood at $68.2 million (up 20.89% YoY), and the FY2025 full-year result was $61.9 million, up 10.2% from the prior year.
• Revenue improved to $18.5 million in Q2 2026 per DERM's latest filing, from $16.0 million in the prior quarter.
• Across five years, Revenue topped out at $34.5 million in Q3 2023 and bottomed at $12.2 million in Q1 2023.
• Historically, Revenue has averaged $17.0 million across 5 years, with a median of $16.0 million in 2022.
• The sharpest annual moves came in 2022 and 2024: Revenue surged 117.33% in 2022, then tumbled 57.64% in 2024.
• Over 5 years, Revenue stood at $16.0 million in 2022, then slipped by 4.44% to $15.3 million in 2023, then retreated by 10.73% to $13.6 million in 2024, then advanced by 18.05% to $16.1 million in 2025, then gained by 15.12% to $18.5 million in 2026.
• According to Business Quant data, Revenue over the past three periods registered $18.5 million, $16.0 million, and $16.1 million for Q2 2026, Q1 2026, and Q4 2025 respectively.